Related Experiment Video
Updated: Feb 12, 2026

Asthma Detection Research Based on Voice Signal Processing and Machine Learning
Published on: July 22, 2025
Advances in industrial biopharmaceutical batch process monitoring: Machine-learning methods for small data problems
Aditya Tulsyan1, Christopher Garvin2, Cenk Ündey3
1Digital Integration and Predictive Technologies, Amgen, Inc., Cambridge, Massachusetts.
This study introduces a novel machine learning approach to solve the "Low-N" problem in biopharmaceutical manufacturing, enabling robust real-time batch process monitoring (BPM) even with limited historical data.
Area of Science:
- Biopharmaceutical Manufacturing
- Process Analytical Technology (PAT)
- Machine Learning in Quality Control
Background:
- Real-time multivariate statistical batch process monitoring (BPM) is crucial for ensuring quality and detecting deviations in biopharmaceutical manufacturing.
- The "Low-N" problem, characterized by limited production history, hinders the effective deployment of multivariate BPM.
- Current industry practice involves switching to univariate BPM, risking the detection of critical process deviations.
Purpose of the Study:
- To address the industry-wide "Low-N" problem in biopharmaceutical batch process monitoring.
- To propose and validate a novel approach for generating synthetic batch data to overcome limitations of small historical datasets.
- To enable robust multivariate BPM even with limited product history.
Main Methods:
- Development of a machine learning-based methodology combined with hardware exploitation to generate a large number of in silico (simulated) batches.
- Application of the proposed approach to address the "Low-N" challenge in batch process monitoring.
- Validation through several industrial case studies in bulk drug substance manufacturing.
Main Results:
- Successful generation of an arbitrarily large number of in silico batches, effectively simulating extensive production history.
- Demonstration of the proposed approach's efficacy in diverse Low-N scenarios within bulk drug substance manufacturing.
- Overcoming the limitations of traditional univariate monitoring for processes with insufficient historical data.
Conclusions:
- The proposed machine learning and hardware exploitation method offers a viable solution to the "Low-N" problem in biopharmaceutical BPM.
- This innovative approach enhances process monitoring capabilities, mitigating risks associated with limited historical data.
- This represents the first application of machine learning to solve the "Low-N" problem in this manufacturing sector.
More Related Videos
11:38Author Spotlight: Enhancing PSC-to-Functional Cell Differentiation Using ML Models Based on Live-Cell Bright-Field Imaging
Published on: October 4, 2024
09:34A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
Published on: September 25, 2021
Related Concept Videos
Extraction: Advanced Methods
Biopharmaceutics and Pharmacokinetics: Overview
The Scientific Method in Nursing Process
When using research findings to change practice, one must understand the process used to guide a study. The scientific method is a systematic, step-by-step process that supports the data's validity, reliability, and generalizability. As a result, findings can be...
Machines
A free-body diagram of the...
Statistical Methods for Analyzing Epidemiological Data
Microorganisms in Agriculture and Food industry